Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Viragen to file IND for Omniferon, enroll additional patients in HCV trial

Aug. 17, 2000

Tachykinin antagonists discovered at Nippon Zoki

Aug. 11, 2000

Maxim and Roche to develop combination therapy for hepatitis C and cancer

Aug. 11, 2000

Gene for gastroesophageal reflux disease mapped

Aug. 10, 2000

Study commences to evaluate long-term benefit of chronic hepatitis C treatment

Aug. 10, 2000

Zadaxin receives expanded marketing approval in Argentina

Aug. 10, 2000

Forest licenses dexloxiglumide from Rotta for treatment of IBS

Aug. 8, 2000

SciClone begins marketing and distribution of Zadaxin in Mexico

Aug. 7, 2000

Mitsubishi Chemical patents amide derivatives active against H. pylori

Aug. 4, 2000

FDA grants orphan drug status to ALX-0600 as treatment of short bowel syndrome

Aug. 4, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...